Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Kadestone Capital Corp.
  6. News
  7. Summary
    KDSX   CA4828461026

KADESTONE CAPITAL CORP.

(KDSX)
Delayed Bourse de Toronto  -  09:30 2022-09-23 am EDT
1.500 CAD    0.00%
08/24KADESTONE CAPITAL : Management Discussion & Analysis - Q2 2022
PU
08/24KADESTONE CAPITAL : CEO Certification - Q2 2022
PU
08/19Kadestone Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Kadestone Capital Corp. Announces Appointment of Dr. Anthony Holler as Chair

06/27/2022 | 11:23pm EDT

Kadestone Capital Corp. has appointed Dr. Anthony Holler as Chair of Board following the Company's annual general meeting of shareholders of the Company (the "Shareholders") held on June 24, 2022 in Vancouver, British Columbia (the "Meeting"). Dr. Holler was CEO of ID Biomedical from 1999 until 2005 when the company was sold to GlaxoSmithKline for $1.7 billion.

He currently serves as the Chairman of the Board of Perimeter Medical Imaging AI Inc. and CEO and Chairman of the Board for Sunniva Inc. Previously, Dr. Holler was Chairman of the Board of Directors of CRH Medical from December 2005 to March 2020. Dr. Holler was also Chairman of Corriente Resources Inc., which sold for approximately $700 million to CRCC-Tongguan Investment Co. in 2010.

Before his involvement in public markets, Dr. Holler served as an Emergency Physician at University Hospital at the University of British Columbia. He holds a Bachelor of Science Degree and a Medical Degree from the University of British Columbia.


© S&P Capital IQ 2022
All news about KADESTONE CAPITAL CORP.
08/24KADESTONE CAPITAL : Management Discussion & Analysis - Q2 2022
PU
08/24KADESTONE CAPITAL : CEO Certification - Q2 2022
PU
08/19Kadestone Capital Corp. Reports Earnings Results for the Second Quarter and Six Months ..
CI
08/19Kadestone capital corp. reports q2 2022 financial results
AQ
08/04KADESTONE CAPITAL : Reports q1 2022 financial results
PU
08/04KADESTONE CAPITAL : Announces appointment of dr. anthony holler as chair
PU
06/28KADESTONE CAPITAL BRIEF : Overnight Monday Appointed Dr. Anthony Holler As Chair
MT
06/27Kadestone Capital Corp. Announces Appointment of Dr. Anthony Holler as Chair
CI
06/01KADESTONE CAPITAL : Management Discussion & Analysis - Q1 2022
PU
05/20Kadestone Capital Q1 Net Loss Widens to $0.02 Per Share Vs $0.01 Per Share Year Ago
MT
More news
Financials
Sales 2021 0,21  0,15  0,15 
Net income 2021 -2,89 M -2,13 M -2,13 M
Net Debt 2021 3,67 M 2,71 M 2,71 M
P/E ratio 2021 -28,2x
Yield 2021 -
Capitalization 69,8 M 51,4 M 51,4 M
EV / Sales 2020 -
EV / Sales 2021 406 719 513x
Nbr of Employees -
Free-Float 33,5%
Chart KADESTONE CAPITAL CORP.
Duration : Period :
Kadestone Capital Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Brent Billey President, Chief Executive Officer & Director
David Negus Chief Financial Officer & Secretary
Anthony F. Holler Chairman
David Negrin Independent Director
Norman Joseph Mayr Independent Director